César Pablo Ramírez. Hospital Quironsalud Málaga. Málaga, Spain

Fernando Martínez Regueira. Clínica Universidad de Navarra. Pamplona, Spain

  • Combined nabpaclitaxel pressurized intraperitoneal aerosol chemotherapy with systemic nabpaclitaxel-gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: the interim analisys of nab-pipac trial
    Andrea di Giorgio. Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Roma, Italy
  • The influence of synchronous or metachronous liver metastases on outcomes of patients with colorectal cancer peritoneal metastases
    Marco Antonio Achurra Olmos. Instituto Oncológico Nacional: ION. Panama, Panama
  • Tailoring hipec with patient-derived organoids in colorectal peritoneal metastases. Results from the first stage of the prospective phase ii organohipec clinical trial (clinicaltrials.gov – NCT06057298)
    Dario Carlo Angelo Baratti. Fondazione IRCCS Istituto Nazionale dei Tumori. Milano, Italy
  • Cost-effectiveness analysis of dedicated MR imaging versus surgical staging in patients with colorectal peritoneal metastases
    Max Lahaye. The Netherlands Cancer Institute Antoni Van Leeuwenhoek. Amsterdam, The Netherlands
  •  Superior surgical planning with 15-min delayed CT: precise preoperative evaluation and resectability prediction in pseudomyxoma peritonei
    Nan Zhou. Aerospace Center Hospital. Beijing, China
  • National consensus on the definition of a textbook oncologic outcome (TOO) for cytoreductive surgery with hipec in peritoneal surface malignancies
    Manuela Robella. Candiolo Cancer Institute, FPO – IRCCS. Candiolo, Italy
  • A radiomics-based interpretable model integrating delayed-phase CT and clinical features for predicting the pathological grade of appendiceal pseudomyxoma peritonei
    Dong Bai. Aerospace Center Hospital. Beijing, China
  • All roads lead to Rome: convergence of biological themes in tumour microenvironment using multiomics analysis unravelled new intraperitoneal therapeutic strategies for peritoneal metastases
    Johnny Ong. National Cancer Centre Singapore. Singapore
  • Microbial signatures in pseudomyxoma peritonei: first evidence of mucus-producing bacteria and fungi in soft mucin
    Antonio Romero. University of Cordoba. Córdoba, Spain
October 29 @ 09:00
09:00 — 10:30 (1h 30′)